<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T01:01:06Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6819548" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6819548</identifier>
        <datestamp>2019-10-31</datestamp>
        <setSpec>bmcid</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Infect. Dis</journal-id>
              <journal-title-group>
                <journal-title>BMC Infectious Diseases</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-2334</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6819548</article-id>
              <article-id pub-id-type="pmcid">PMC6819548</article-id>
              <article-id pub-id-type="pmc-uid">6819548</article-id>
              <article-id pub-id-type="pmid">31660883</article-id>
              <article-id pub-id-type="pmid">31660883</article-id>
              <article-id pub-id-type="publisher-id">4540</article-id>
              <article-id pub-id-type="doi">10.1186/s12879-019-4540-z</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6147-3547</contrib-id>
                  <name>
                    <surname>Otiende</surname>
                    <given-names>Verrah</given-names>
                  </name>
                  <address>
                    <email>otiende.verrah@students.jkuat.ac.ke</email>
                    <email>verrahodhiambo@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Achia</surname>
                    <given-names>Thomas</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mwambi</surname>
                    <given-names>Henry</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <aff id="Aff1"><label>1</label>Department of Mathematical Sciences, Pan African University Institute of Basic Sciences Technology and Innovation, Nairobi, Kenya </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0723 4123</institution-id><institution-id institution-id-type="GRID">grid.16463.36</institution-id><institution>School of Mathematics, Statistics &amp; Computer Science, </institution><institution>University of KwaZulu-Natal, </institution></institution-wrap>Pietermaritzburg, South Africa </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>10</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>28</day>
                <month>10</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>19</volume>
              <elocation-id>902</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>4</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>9</day>
                  <month>10</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s). 2019</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) diseases are globally acknowledged as a public health challenge that exhibits adverse bidirectional relations due to the co-epidemic overlap. To understand the co-infection burden we used the case notification data to generate spatiotemporal maps that described the distribution and exposure hypotheses for further epidemiologic investigations in areas with unusual case notification levels.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">We analyzed the TB and TB-HIV case notification data from the Kenya national TB control program aggregated for forty-seven counties over a seven-year period (2012–2018). Using spatiotemporal poisson regression models within the Integrated Nested Laplace Approach (INLA) paradygm, we modeled the risk of TB-HIV co-infection. Six competing models with varying space-time formulations were compared to determine the best fit model. We then assessed the geographic patterns and temporal trends of coinfection risk by mapping the posterior marginal from the best fit model.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Of the total 608,312 TB case notifications, 194,129 were HIV co-infected. The proportion of TB-HIV co-infection was higher in females (39.7%) than in males (27.0%). A significant share of the co-infection was among adults aged 35 to 44 years (46.7%) and 45 to 54 years (42.1%). Based on the Bayesian Defiance Information (DIC) and the effective number of parameters (<italic>pD</italic>) comparisons, the spatiotemporal model allowing space-time interaction was the best in explaining the geographical variations in TB-HIV coinfection. The model results suggested that the risk of TB-HIV coinfection was influenced by infrastructure index (Relative risk (RR) = 5.75, Credible Interval (Cr.I) = (1.65, 19.89)) and gender ratio (RR = 5.81e<sup>−04</sup>, Cr. I = (1.06e<sup>−04</sup>, 3.18e<sup>−03</sup>). The lowest and highest temporal relative risks were in the years 2016 at 0.9 and 2012 at 1.07 respectively. The spatial pattern presented an increased co-infection risk in a number of counties. For the spatiotemporal interaction, only a few counties had a relative risk greater than 1 that varied in different years.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">We identified elevated risk areas for TB/HIV co-infection and fluctuating temporal trends which could be because of improved TB case detection or surveillance bias caused by spatial heterogeneity in the co-infection dynamics. Focused interventions and continuous TB-HIV surveillance will ensure adequate resource allocation and significant reduction of HIV burden amongst TB patients.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Bayesian modeling</kwd>
                <kwd>TB-HIV co-infection</kwd>
                <kwd>co-epidemic burden</kwd>
                <kwd>Kenya</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>African Union</institution>
                  </funding-source>
                  <award-id>PhD Scholarship</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par17">Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) diseases have a co-epidemic relation such that the chronic immune prompt arising from TB disease hastens HIV disease advancement [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Both the TB and HIV pathogens interact collectively, accelerating the progress of illness thereby increasing the chances of death [<xref ref-type="bibr" rid="CR3">3</xref>]. Globally, TB and HIV exhibit an adverse bidirectional interaction because of the co-epidemic overlap. The risk of TB infection developing into TB disease is between 16 and 27 times higher in HIV infected persons [<xref ref-type="bibr" rid="CR4">4</xref>]. TB can occur both in the early stages and through all stages of HIV infection although the risk intensifies soon after infection with HIV [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
              <p id="Par18">Under the same degree of exposure, there exists no irrefutable evidence that HIV positive persons are more likely to acquire TB infection than HIV negative persons [<xref ref-type="bibr" rid="CR6">6</xref>]. However, the risk of rapid progression once TB infection occurs is greater among persons living with HIV infection [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The lifetime risk for HIV negative individuals to develop active TB from latent TB is about 5 to 10%, whereas, for persons living with HIV, the same percentage holds but annually opposed to a lifetime [<xref ref-type="bibr" rid="CR9">9</xref>]. Studies by [<xref ref-type="bibr" rid="CR10">10</xref>] and [<xref ref-type="bibr" rid="CR11">11</xref>] in various outbreak settings confirm that HIV co-infection does intensify the progression of latent TB to active TB disease. The diagnosis of TB in the HIV epidemic remains extremely challenging because of the difficulty in differentiating between reactivation and recent infections [<xref ref-type="bibr" rid="CR12">12</xref>]. The risk of infection or reinfection is dependent on the source case numbers in various congregate settings including households and health-care facilities [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
              <p id="Par19">The disparity for TB infections between persons with and without HIV infection remains a global concern especially because of the high incidence rate among HIV infected persons [<xref ref-type="bibr" rid="CR13">13</xref>]. A study by [<xref ref-type="bibr" rid="CR14">14</xref>] observed that the prevalence of HIV infections for persons reporting prior TB disease was 33.2% compared to 5.1% in persons without prior TB. Another study by [<xref ref-type="bibr" rid="CR13">13</xref>] confirmed that TB disease incidence among HIV infected persons was still eight times higher than in persons without HIV. In the year 2015, the global estimation of TB disease was 10.4 million of which 11% were HIV positive [<xref ref-type="bibr" rid="CR15">15</xref>]. Approximately 60% of the TB/HIV co-infected patients received neither diagnosis nor treatment leading to 390,000 TB related deaths [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
              <p id="Par20">Globally, sub-Saharan Africa accounts for the largest percentage of the dual epidemic with co-morbidity from TB-HIV remaining a critical public health challenge [<xref ref-type="bibr" rid="CR14">14</xref>]. In essence, more people die from TB than HIV associated infections [<xref ref-type="bibr" rid="CR17">17</xref>]. In 2016 alone, the SSA region accounted for an estimated 86% of HIV-linked TB deaths [<xref ref-type="bibr" rid="CR18">18</xref>]. Kenya is one of the countries in SSA severely hit by the dual epidemic and appears among the WHO high TB and TB-HIV burden countries ranking 13 out of the 22 countries globally [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The impact of TB-HIV co-infection in Kenya is evident mainly because of the complications in diagnosis and management. Equally, the HIV surveillance on TB patients and the TB surveillance on HIV patients in Kenya relies primarily on the self-reported cases from health facilities as a surrogate measure of the actual co-endemic. The two surveillance systems are not integrated making it a challenge to profile the actual co-infection burden. Therefore, the feasibility of using case notifications instead of population-based studies to capture the valid spatiotemporal co-infection incidence estimates of the co-epidemic is unknown.</p>
              <p id="Par21">Against this background, we investigate the geographical variation and co-infection burden using the case notification data for a 7-year period and characterize the areas with unusually high relative risks. We utilize the space-time disease mapping models which allow for the concurrent study of persistent and unusual co-infection trends, thus offering additional benefits over purely spatial disease mapping models [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. These model-maps describe new exposure hypotheses that warrant further epidemiologic investigations in areas with unusual case notification levels and ultimately inform relevant geographically based interventions and resource allocation towards suppressing further infections.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Data sources</title>
                <p id="Par22">We conducted this study through extensive analysis of TB case notification data from the Kenya national TB control program database. The database is an elaborate and robust surveillance system that captures case notification data from the health facilities in every county and updates the records on the national grid. For the process of data capture into the surveillance system, the National TB program adapted both the recording and reporting tools from WHO. The WHO recommends systematic screening for HIV among TB patients; our dataset captures the HIV status of all the TB case notifications. We analyze the data aggregated at the county level.</p>
              </sec>
              <sec id="Sec4">
                <title>Model description</title>
                <p id="Par23">For the county s in the year t, we modeled the TB-HIV cases notification y<sub>st</sub> as
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\mathrm{y}}_{\mathrm{st}}\sim \mathrm{Poisson}\left({\uplambda}_{\mathrm{st}}\right) $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:msub><mml:mi mathvariant="normal">y</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>~</mml:mo><mml:mtext>Poisson</mml:mtext><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="normal">λ</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:mfenced></mml:math><graphic xlink:href="12879_2019_4540_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par24">We assumed our count data follows the Poisson distribution where the log of the relative risks was the focus of modeling. We defined the mean λ<sub>st</sub> in terms of the unknown relative risk and expected number of co-infection cases. That is, λ<sub>st</sub> = ρ<sub>st</sub>E<sub>st</sub>.</p>
                <p id="Par25">We defined the population at risk of TB-HIV co-infection are the TB cases. We computed the expected counts of co-infection cases E<sub>st</sub> per county per year. These counts represent the number of cases one would expect if the population of county s has similar behavior to the standard population. Our statistical consideration for the standard population N was the average of the pooled TB cases, that is, <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{N}=\frac{\mathrm{P}}{\mathrm{Y}} $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">N</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">Y</mml:mi></mml:mfrac></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq1.gif"/></alternatives></inline-formula>, where P is the total number of TB cases at risk of co-infection and Y is the number of years, which is seven for this study. We calculated the crude rate as <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\mathrm{R}}_{\mathrm{st}}=\frac{\sum {\mathrm{X}}_{\mathrm{st}}}{{\mathrm{P}}_{\mathrm{st}}} $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="normal">R</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>∑</mml:mo><mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:mfrac></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq2.gif"/></alternatives></inline-formula> where ∑X<sub>st</sub> and P<sub>st</sub> are the number of co-infection cases and the number of TB cases in county s, year t respectively. We then multiplied the crude rate by the standard population to obtain the expected number of co-infection cases
<disp-formula id="Equb"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\mathrm{E}}_{\mathrm{st}}={\mathrm{R}}_{\mathrm{st}}\times \mathrm{N} $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:msub><mml:mi mathvariant="normal">E</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">R</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>×</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:math><graphic xlink:href="12879_2019_4540_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par26">We expressed the linear predictor on the logarithmic scale, η<sub>st</sub> = log(ρ<sub>st</sub>) which is the recommended invertible link function for the Poisson family of distributions. We compared the spatiotemporal disease models discussed by [<xref ref-type="bibr" rid="CR23">23</xref>]. The models differed in their formulation of the space-time structure and the inclusion or not of the covariates. Model 1a applied the classical parametric formulation of [<xref ref-type="bibr" rid="CR24">24</xref>] on the linear predictor, which we expressed as
<disp-formula id="Equ1"><label>1a</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+\left(\uprho +{\updelta}_{\mathrm{s}}\right)\times {\mathrm{Z}}_{\mathrm{t}} $$\end{document}</tex-math><mml:math id="M10" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">ρ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:msub><mml:mi mathvariant="normal">Z</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par27">The formulation included the spatially structured (υ<sub>s</sub>) and unstructured (ν<sub>s</sub>) random effects, the global linear time trend effect (ρ × Z<sub>t</sub>). The term δ<sub>s</sub> × Z<sub>t</sub> is the interaction term between space and time defining the difference between ρ and the area-specific time trend. It is referred to as the differential trend of the s<sup>th</sup> area [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The term Z<sub>t</sub> is a vector of temporal weights and the intercept α quantifies the average co-infection rate in all the 47 counties. Each spatial unit has its own time trend with a spatial intercept (α + υ<sub>s</sub> + ν<sub>s</sub>) and a slope (ρ + δ<sub>s</sub>). This model assumes a linear time trend in each spatial unit. We estimated the parameters θ = {α, ρ, ν, υ, δ} and the hyper-parameters ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>δ</sub>}.</p>
                <p id="Par28">The model 1b included the covariates to the model 1a thereby estimating θ = {α, β, ρ, ν, υ, δ} and ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>δ</sub>}. The model expression was
<disp-formula id="Equ2"><label>1b</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +\sum {\upbeta}_{\mathrm{i}}{\mathrm{x}}_{\mathrm{i}}+{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+\left(\uprho +{\updelta}_{\mathrm{s}}\right)\times {\mathrm{Z}}_{\mathrm{t}} $$\end{document}</tex-math><mml:math id="M12" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:mo>∑</mml:mo><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">ρ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:msub><mml:mi mathvariant="normal">Z</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par29">The model 2a used the dynamic non-parametric formulation on the linear predictor
<disp-formula id="Equ3"><label>2a</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+{\upgamma}_{\mathrm{t}}+{\upphi}_{\mathrm{t}} $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">γ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ϕ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par30">The terms α, υ<sub>s</sub> and ν<sub>s</sub> are similar to the formulation in the first model, additionally, the terms γ<sub>t</sub> and ϕ<sub>t</sub> represents the temporally structured and unstructured random effect respectively. The model assumes a non-parametric time trend. In this formulation, θ = {α, ν, υ, γ, ϕ} and ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>γ</sub>, τ<sub>ϕ</sub>}.</p>
                <p id="Par31">The model 2b incorporated the covariates to the model 2a to estimate θ = {α, β, ν, υ, γ, ϕ} and ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>γ</sub>, τ<sub>ϕ</sub>}. We expressed model 2b as
<disp-formula id="Equ4"><label>2b</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +\sum {\upbeta}_{\mathrm{i}}{\mathrm{x}}_{\mathrm{i}}+{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+{\upgamma}_{\mathrm{t}}+{\upphi}_{\mathrm{t}} $$\end{document}</tex-math><mml:math id="M16" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:mo>∑</mml:mo><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">γ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ϕ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par32">Our model 3a expanded the model 2a by allowing a space-time interaction to explain for the difference in the time trend of TB-HIV coinfection for the diverse counties.
<disp-formula id="Equ5"><label>3a</label><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+{\upgamma}_{\mathrm{t}}+{\upphi}_{\mathrm{t}}+{\updelta}_{\mathrm{s}\mathrm{t}} $$\end{document}</tex-math><mml:math id="M18" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">γ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ϕ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par33">For this model, θ = {α, ν, υ, γ, ϕ, δ} and ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>γ</sub>, τ<sub>ϕ</sub>, τ<sub>δ</sub>}. We defined δ<sub>st</sub> as the interaction between ν<sub>s</sub> and ϕ<sub>t</sub> consequently assuming no interaction between υ<sub>s</sub> and γ<sub>t</sub> therefore δ<sub>st</sub>~N(0, τ<sub>δ</sub>).</p>
                <p id="Par34">The final model 3b incorporated the covariates to the model 3a to estimate θ = {α, β, ν, υ, γ, ϕ, δ} and ψ = {τ<sub>ν</sub>, τ<sub>υ</sub>, τ<sub>γ</sub>, τ<sub>ϕ</sub>, τ<sub>δ</sub>}. We formulated the model as
<disp-formula id="Equ6"><label>3b</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upeta}_{\mathrm{s}\mathrm{t}}=\upalpha +\sum {\upbeta}_{\mathrm{i}}{\mathrm{x}}_{\mathrm{i}}+{\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}+{\upgamma}_{\mathrm{t}}+{\upphi}_{\mathrm{t}}+{\updelta}_{\mathrm{s}\mathrm{t}} $$\end{document}</tex-math><mml:math id="M20" display="block"><mml:msub><mml:mi mathvariant="normal">η</mml:mi><mml:mi>st</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">α</mml:mi><mml:mo>+</mml:mo><mml:mo>∑</mml:mo><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">γ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ϕ</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:math><graphic xlink:href="12879_2019_4540_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par35">To assess the performance of these six models, we used the DIC taking into consideration the complexity of the models. We selected the model with the lowest DIC as the best-fit model.</p>
              </sec>
              <sec id="Sec5">
                <title>Baseline predictor variables</title>
                <p id="Par36">The set of baseline predictors were poverty index, infrastructure index, health index, education index, gender ratio, dependency ratio, and Gini coefficient. These predictors are standard indices used to establish the comparative level of development of different counties in Kenya. The computation of these indices is further elaborated in the reports from [<xref ref-type="bibr" rid="CR25">25</xref>] and [<xref ref-type="bibr" rid="CR26">26</xref>]. All these predictor variables were fitted in the models 1b, 2b and 3b but only the significant ones were considered in the discussion.</p>
                <p id="Par37">The poverty index provides a measure of the inadequate consumption of is services and fundamental rights. In other words, it estimates the disparities in resource expenditures for each county. The infrastructure index captures access to natural resources, economic growth, and innovative planning. The health index measures access to medical services, adequate medical workforce, and improved medical productivity. The education index captures the literacy attainment, completion and dropout rate. The gender inequality index reflects the bias in reproductive health, empowerment and labor market between men and women. The dependency ratio gives an indication of the burden of the working population and government to support the non-working population who are either too young or too old. The Gini coefficient compares the distribution of income in the entire population of any given county. It is based on the Lorenz curve and varies between 0 (complete equality) and 1 (complete inequality).</p>
              </sec>
              <sec id="Sec6">
                <title>Statistical analysis</title>
                <p id="Par38">For the demographic characterization of the case notifications, we compared the summaries of TB cases with and without HIV infections. We stratified the data based on HIV status and performed the chi-square test to determine the association between HIV status and each of the demographic variables TB-type, age, gender, and patient type. All the <italic>p</italic>-values were two-tailed with values less than 0.05 considered being statistically significant. The TB type classification was either pulmonary TB or extra-pulmonary TB. Pulmonary TB referring to a patient with TB disease involving the lung parenchyma whereas the extra-pulmonary TB involves any organ other than the lungs. For the patient type, we had five categories; the first was the default category for patients who defaulted the TB therapy then experienced recurrence. The second was the failed category for patients previously diagnosed with TB but never took on the therapy. The third category was for newly diagnosed patients without previous TB diagnosis or therapy. The relapse case was the fourth category whereby patients were previously diagnosed, treated of TB and completed the TB therapy but experienced a recurrence. The fifth and final category was the cases transferred in from other health facilities to continue with the therapy.</p>
                <p id="Par39">Using the Integrated Nested Laplace Approach (INLA), we fitted the case notification data to our spatiotemporal disease models to determine the best fit. We assessed the nature of the response variables on our baseline predictors. We specified the Besag-York-Mollie (BYM) prior on <italic>υ</italic><sub><italic>s</italic></sub> using the intrinsic conditional autoregressive structure (iCAR). Thus <inline-formula id="IEq3"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upupsilon}_{{\mathrm{s}}_{\mathrm{i}}}\mid {\upupsilon}_{{\mathrm{s}}_{\mathrm{i}}\ne {\mathrm{s}}_{\mathrm{j}}}\sim \mathrm{N}\left(\frac{\sum_{\mathrm{j}\upepsilon \mathrm{N}\left(\mathrm{s}\right)}{\upupsilon}_{{\mathrm{s}}_{\mathrm{j}}}}{\#\mathrm{N}\left(\mathrm{s}\right)},\frac{\upsigma_{\upupsilon}^2}{\#\mathrm{N}\left(\mathrm{s}\right)}\right) $$\end{document}</tex-math><mml:math id="M22" display="inline"><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:msub><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:msub><mml:mo>∣</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mrow><mml:msub><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo>≠</mml:mo><mml:msub><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">j</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mo>~</mml:mo><mml:mi mathvariant="normal">N</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mfrac><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>jϵN</mml:mi><mml:mfenced close=")" open="("><mml:mi mathvariant="normal">s</mml:mi></mml:mfenced></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:msub><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">j</mml:mi></mml:msub></mml:msub></mml:mrow><mml:mrow><mml:mo>#</mml:mo><mml:mi mathvariant="normal">N</mml:mi><mml:mfenced close=")" open="("><mml:mi mathvariant="normal">s</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mfrac><mml:msubsup><mml:mi mathvariant="normal">σ</mml:mi><mml:mi mathvariant="normal">υ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo>#</mml:mo><mml:mi mathvariant="normal">N</mml:mi><mml:mfenced close=")" open="("><mml:mi mathvariant="normal">s</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq3.gif"/></alternatives></inline-formula> where #N(s) is the number of neighbors sharing boundaries with the county s<sub>i</sub>. The BYM model allows us to capture both the heterogeneity (variability) and clustering of disease risk simultaneously. We then used the exchangeable prior on ν<sub>s</sub>, that is <inline-formula id="IEq4"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upnu}_{\mathrm{s}}\sim \mathrm{N}\left(0,{\upsigma}_{\upnu}^2\right) $$\end{document}</tex-math><mml:math id="M24" display="inline"><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>~</mml:mo><mml:mi mathvariant="normal">N</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mn>0</mml:mn><mml:msubsup><mml:mi mathvariant="normal">σ</mml:mi><mml:mi mathvariant="normal">ν</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq4.gif"/></alternatives></inline-formula>. We modeled γ<sub>t</sub> using a random walk specified through the temporal adjacency structure, which is analogous to the spatially structured random effects specification as it borrows strength from adjacent time periods. The temporally unstructured random effect ϕ<sub>t</sub> was modeled using the Gaussian exchangeable prior ϕ<sub>t</sub>~N(0, τ<sub>ϕ</sub>). We defined improper priors for the intercept and regression coefficients of the fixed effects as α~N(0, 0) and β~N(0, 0.001) respectively. For the distribution of the hyper-parameters, we assumed the default specifications of INLA whereby we assigned minimally informative priors on the log of the precision of both the structured and unstructured effects ψ~(1,0.0005).</p>
              </sec>
            </sec>
            <sec id="Sec7">
              <title>Results</title>
              <sec id="Sec8">
                <title>Demographic characterization of TB-HIV case notification in Kenya, 2012–2018</title>
                <p id="Par40">Of the total 608,312 TB case notification for the period 2012–2018 included in the study, 194,129 cases were HIV co-infected, 391,030 cases were HIV uninfected and 23,153 cases were unaware of their HIV status because either the HIV test was not done or they declined to be tested. The demographic characteristics of TB patients stratified by HIV status are in Table <xref rid="Tab1" ref-type="table">1</xref>. The TB case notification decreased from 99,586 (16.4%) in 2012 to 78,318 (12.6%) in 2016 but increased to 85,886 (14.1%) in 2017 and 83,324 (13.7%) in 2018. Similarly, the co-infection cases decreased from 36,135 (36.3%) in 2012 to 21,896 (26.3%) in 2018. The chi-square test showed that HIV status was positively associated with age, time of case notification, type of TB, gender and TB patient type (<italic>p</italic>-value &lt; 0.01).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic characterization of TB patients with and without HIV in Kenya (2012–2018)</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>All [n (%)]</th><th>HIV uninfected [n (%)]</th><th>HIV co-infected [n (%)]</th><th>HIV unknown [n (%)]</th><th>χ<sup>2</sup>(df, <italic>p</italic>-value)</th></tr></thead><tbody><tr><td colspan="5">Year</td><td char="(" align="char" rowspan="8">6112.3 (12, &lt; 0.01)</td></tr><tr><td> 2012</td><td>99,586 (16.4)</td><td>58,967 (59.2)</td><td>36,135 (36.3)</td><td>4484 (4.5)</td></tr><tr><td> 2013</td><td>90,674 (14.9)</td><td>53,562 (59.1)</td><td>32,099 (35.4)</td><td>5013 (5.5)</td></tr><tr><td> 2014</td><td>90,123 (14.8)</td><td>55,593 (61.7)</td><td>30,472 (33.8)</td><td>4058 (4.5)</td></tr><tr><td> 2015</td><td>82,401 (13.5)</td><td>53,617 (65.1)</td><td>26,616 (32.3)</td><td>2168 (2.6)</td></tr><tr><td> 2016</td><td>78,318 (12.9)</td><td>50,393 (64.3)</td><td>23,051 (29.4)</td><td>2874 (3.7)</td></tr><tr><td> 2017</td><td>85,886 (14.1)</td><td>59,535 (69.3)</td><td>23,860 (27.8)</td><td>2491 (2.9)</td></tr><tr><td> 2018</td><td>83,324 (13.7)</td><td>59,363 (71.2)</td><td>21,896 (26.3)</td><td>2065 (2.5)</td></tr><tr><td colspan="5">TB Type</td><td char="(" align="char" rowspan="3">1422.1 (2, &lt; 0.01)</td></tr><tr><td> Extra-pulmonary TB</td><td>102,072 (16.8)</td><td>60,643 (59.4)</td><td>36,344 (35.6)</td><td>5085 (5.0)</td></tr><tr><td> Pulmonary TB</td><td>506,240 (83.2)</td><td>330,387 (65.3)</td><td>157,785 (31.2)</td><td>18,068 (3.6)</td></tr><tr><td colspan="5">Age Category</td><td char="(" align="char" rowspan="7">38,896 (12, &lt; 0.01)</td></tr><tr><td>  &lt; 15</td><td>57,591 (9.5)</td><td>40,813 (70.9)</td><td>13,327 (23.1)</td><td>3451 (6.0)</td></tr><tr><td> 15–24</td><td>108,104 (17.8)</td><td>87,171 (80.6)</td><td>16,438 (15.2)</td><td>4495 (4.2)</td></tr><tr><td> 25–34</td><td>172,114 (28.3)</td><td>106,384 (61.8)</td><td>60,046 (34.9)</td><td>5682 (3.3)</td></tr><tr><td> 35–44</td><td>130,106 (21.4)</td><td>65,507 (50.3)</td><td>60,808 (46.7)</td><td>3791 (2.9)</td></tr><tr><td> 45–54</td><td>71,743 (11.8)</td><td>38,889 (54.2)</td><td>30,229 (42.1)</td><td>2615 (3.6)</td></tr><tr><td> 55+</td><td>68,656 (11.3)</td><td>52,256 (76.1)</td><td>13,281 (19.3)</td><td>3119 (4.5)</td></tr><tr><td colspan="5">Gender</td><td char="(" align="char" rowspan="3">10,796 (2, &lt; 0.01)</td></tr><tr><td> Female (F)</td><td>233,903 (38.45)</td><td>132,494 (56.6)</td><td>92,970 (39.7)</td><td>8439 (3.6)</td></tr><tr><td> Male (M)</td><td>374,409 (61.5)</td><td>258,536 (69.1)</td><td>101,159 (27.0)</td><td>14,714 (3.9)</td></tr><tr><td colspan="5">Patient Type</td><td char="(" align="char" rowspan="6">2681.4 (8, &lt; 0.01)</td></tr><tr><td> Default (D)</td><td>8889 (1.5)</td><td>5335 (60.0)</td><td>3336 (37.5)</td><td>218 (2.5)</td></tr><tr><td> Failed (F)</td><td>1547 (0.3)</td><td>1068 (69.0)</td><td>457 (29.5)</td><td>22 (1.4)</td></tr><tr><td> New (N)</td><td>551,231 (90.6)</td><td>358,430 (65.0)</td><td>171,115 (31.0)</td><td>21,686 (3.9)</td></tr><tr><td> Relapse (R)</td><td>40,020 (6.6)</td><td>21,862 (54.6)</td><td>17,174 (42.9)</td><td>984 (2.5)</td></tr><tr><td> Transferred In (TI)</td><td>6625 (1.1)</td><td>4335 (65.4)</td><td>2047 (30.9)</td><td>243 (3.7)</td></tr><tr><td>Total (N)</td><td>608,312</td><td>391,030</td><td>194,129</td><td>23,153</td><td/></tr></tbody></table></table-wrap></p>
                <p id="Par41">The male TB case notification exceeded the female but the proportion of TB-HIV co-infection was higher in female cases (39.7%) as compared to male cases (27.0%). The temporal trend of co-infection risk was consistently higher in women (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) whereas the spatial pattern was widespread in males compared to the female. The counties with a high co-infection burden for both males and females were Homabay, Siaya, Kisumu, Migori and Busia counties (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). A significant share of the co-infection was among adults between the ages of 35 to 44 years (46.7%) and 45 to 54 years (42.1%). Patients aged below 25 years and above 54 years registered a considerably lower co-infection risk over time (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The spatial patterns based on age-categories showed a widespread co-infection risk pattern for the ages 25–34 followed by 35–44 years (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). These age categories and generally the most sexually active age ranges, which puts them at a higher risk of co-infection.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Temporal trend of co-infection risk by gender</p></caption><graphic xlink:href="12879_2019_4540_Fig1_HTML" id="MO1"/></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Spatial patterns of co-infection burden by gender</p></caption><graphic xlink:href="12879_2019_4540_Fig2_HTML" id="MO2"/></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><p>Temporal trend of co-infection by age-category</p></caption><graphic xlink:href="12879_2019_4540_Fig3_HTML" id="MO3"/></fig>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Spatial patterns of co-infection burden by age category</p></caption><graphic xlink:href="12879_2019_4540_Fig4_HTML" id="MO4"/></fig></p>
                <p id="Par42">The proportion of extra-pulmonary TB cases co-infected with HIV (35.6%) also surpassed that of pulmonary TB (31.2%). Looking at the patient types, the 194,129 TB-HIV co-infection cases were composed of 171,115 (31.0%) new TB infections, 17,174 (42.9%) TB relapse cases, 457 (29.5%) TB therapy failure cases, 3336 (37.5%) defaulted cases and 2047 (30.9%) transferred in cases.</p>
              </sec>
              <sec id="Sec9">
                <title>Model comparison</title>
                <p id="Par43">In Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref> we present the results of the six hierarchical models including the Deviance Information Criterion (DIC), the effective number of parameters (pD) and the mean deviance (Ď). We compared the spatiotemporal disease models discussed by [<xref ref-type="bibr" rid="CR23">23</xref>], which differed in their formulation of the space-time structure and the inclusion or not of the fixed effects. The values of pD penalize the complexity of the model and smaller values indicate a parsimonious model. For Poisson likelihoods, the pD should be approximately equal to the number of observations [<xref ref-type="bibr" rid="CR27">27</xref>]; that is 47 × 7 = 329. Model 1a has a smaller pD than the number of observations and the biggest DIC, indicating a clear lack of fit. Both criteria thus point to the model 3f being the best fitting model. In this model, the infrastructure index (RR = 5.75, Cr. I = (1.65, 19.89)) and gender ratio (RR = 5.81e<sup>−04</sup>, Cr. I = (1.06e<sup>−04</sup>, 3.18e<sup>−03</sup>)) were significantly associated with TB-HIV co-infection. In the remaining sections, we focus on presenting the results on the model 3b.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Posterior estimates and their 95% credible intervals (CI) for the random effects models</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>1a (95% Cr. I)</th><th>2a (95% Cr. I)</th><th>3a (95% Cr. I)</th></tr></thead><tbody><tr><td colspan="4">Fixed effects:</td></tr><tr><td> (Intercept)</td><td>0.91 (0.73, 1.13)</td><td>0.74 (0.60, 0.91)*</td><td>0.74 (0.61, 0.90)*</td></tr><tr><td> Year</td><td>0.94 (0.92, 0.97)*</td><td>–</td><td>–</td></tr><tr><td colspan="4">Random effects</td></tr><tr><td colspan="4"> Spatial</td></tr><tr><td>  Structured  (<italic>τ</italic><sub><italic>υ</italic></sub>)</td><td>4.64e<sup>02</sup> (1.37e<sup>01</sup>, 3.95e<sup>03</sup>)</td><td>4.34e<sup>02</sup> (1.33e<sup>01</sup>, 3.75e<sup>03</sup>)</td><td>3.29e<sup>03</sup> (6.66e<sup>02</sup>, 1.09e<sup>04</sup>)</td></tr><tr><td>  Unstructured  (<italic>τ</italic><sub><italic>ν</italic></sub>)</td><td>1.96 (1.27, 2.89)</td><td>1.95 (1.27, 2.90)</td><td>2.24 (1.44, 3.31)</td></tr><tr><td colspan="4"> Temporal</td></tr><tr><td>  Structured  (<italic>τ</italic><sub><italic>γ</italic></sub>)</td><td>–</td><td>2.07e<sup>02</sup> (6.68e<sup>01</sup>, 5.28e<sup>02</sup>)</td><td>1.02e<sup>04</sup> (7.23e<sup>02</sup>, 5.91e<sup>04</sup>)</td></tr><tr><td>  Unstructured  (<italic>τ</italic><sub><italic>ϕ</italic></sub>)</td><td>–</td><td>1.21e<sup>04</sup> (9.45e<sup>02</sup>, 6.51e<sup>04</sup>)</td><td>5.65e<sup>02</sup> (1.48e<sup>02</sup>, 2.08e<sup>03</sup>)</td></tr><tr><td colspan="4"> Spatiotemporal</td></tr><tr><td>  Interaction  (<italic>τ</italic><sub><italic>δ</italic></sub>)</td><td>3.48e<sup>03</sup> (1.05e<sup>03</sup>, 9.48e<sup>03</sup>)</td><td>–</td><td>6.64e<sup>01</sup> (5.40 e<sup>01</sup>, 8.15e<sup>01</sup>)</td></tr><tr><td> DIC</td><td>5163.47</td><td>5163.31</td><td>3100.82</td></tr><tr><td> pD</td><td>55.40</td><td>55.40</td><td>268.34</td></tr><tr><td> Md (Ď)</td><td>5108.07</td><td>5107.91</td><td>2832.49</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Posterior estimates and their 95% credible intervals (CI) for the random effects models with covariates</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>1b (95% Cr. I)</th><th>2b (95% Cr. I)</th><th>3b (95% Cr. I)</th></tr></thead><tbody><tr><td colspan="4">Fixed effects:</td></tr><tr><td> (Intercept)</td><td>2.81e<sup>02</sup> (9.49, 8.35e<sup>03</sup>)<sup>a</sup></td><td>2.28e<sup>02</sup> (7.69, 6.77e<sup>03</sup>)<sup>a</sup></td><td>2.02e<sup>02</sup> (7.54, 5.43e<sup>03</sup>)<sup>a</sup></td></tr><tr><td> Year</td><td>0.94 (0.92, 0.97)<sup>a</sup></td><td>–</td><td>–</td></tr><tr><td> Poverty</td><td>3.49 (0.96, 16.95)</td><td>3.49 (0.72, 16.95)</td><td>3.74 (0.81, 17.46)</td></tr><tr><td> Infrastructure</td><td>4.90 (1.40, 17.29)<sup>a</sup></td><td>4.90 (1.40, 17.29)</td><td>5.75 (1.65, 19.89)<sup>a</sup></td></tr><tr><td> Health</td><td>2.56 (0.56, 11.59)</td><td>2.56 (0.56, 11.59)</td><td>1.99 (0.44, 8.94)`</td></tr><tr><td> Education</td><td>0.36 (0.07, 1.86)</td><td>0.36 (0.07, 0.53)<sup>a</sup></td><td>0.40 (0.08, 1.99)</td></tr><tr><td> Gender</td><td>4.71e<sup>−04</sup> (8.36e<sup>−05</sup>, 2.63e<sup>−03</sup>)<sup>a</sup></td><td>4.67e<sup>−04</sup> (8.36e<sup>−05</sup>, 2.63e<sup>−03</sup>)<sup>a</sup></td><td>5.81e<sup>−04</sup> (1.06e<sup>−04</sup>, 3.18e<sup>−03</sup>)<sup>a</sup></td></tr><tr><td> Dependency</td><td>0.94 (0.33, 2.69)</td><td>0.94 (0.32, 2.69)</td><td>1.01 (0.36, 2.83)</td></tr><tr><td> Gini</td><td>1.15 (0.21, 6.23)</td><td>1.15 (0.21, 6.23)</td><td>0.79 (0.14, 4.35)</td></tr><tr><td colspan="4">Random effects</td></tr><tr><td colspan="4"> Spatial</td></tr><tr><td>  Structured  (<italic>τ</italic><sub><italic>υ</italic></sub>)</td><td>4.75e<sup>02</sup> (1.63e<sup>01</sup>, 3.91e<sup>03</sup>)</td><td>4.89e<sup>02</sup> (1.63e<sup>01</sup>, 4.00e<sup>03</sup>)</td><td>3.22e<sup>03</sup> (6.70e<sup>02</sup>, 1.09e<sup>04</sup>)</td></tr><tr><td>  Unstructured  (<italic>τ</italic><sub><italic>ν</italic></sub>)</td><td>8.30 (5.21, 1.27e<sup>01</sup>)</td><td>8.30 (5.21, 1.77e<sup>01</sup>)</td><td>8.96 (5.55, 1.39e<sup>01</sup>)</td></tr><tr><td colspan="4"> Temporal</td></tr><tr><td>  Structured  (<italic>τ</italic><sub><italic>γ</italic></sub>)</td><td>–</td><td>2.06e<sup>02</sup> (6.71e<sup>01</sup>, 5.31e<sup>02</sup>)</td><td>1.08e<sup>04</sup> (7.24e<sup>03</sup>, 5.95e<sup>04</sup>)</td></tr><tr><td>  Unstructured  (<italic>τ</italic><sub><italic>ϕ</italic></sub>)</td><td>–</td><td>1.18e<sup>04</sup> (9.45e<sup>02</sup>, 6.42e<sup>04</sup>)</td><td>5.57e<sup>02</sup> (1.46e<sup>02</sup>, 2.02e<sup>03</sup>)</td></tr><tr><td colspan="4"> Spatiotemporal</td></tr><tr><td>  Interaction  (<italic>τ</italic><sub><italic>δ</italic></sub>)</td><td>3.50e<sup>03</sup> (1.04e<sup>03</sup>, 9.47e<sup>03</sup>)</td><td>–</td><td>6.63e<sup>01</sup> (5.39e<sup>01</sup>, 8.14e<sup>01</sup>)</td></tr><tr><td> DIC</td><td>5162.85</td><td>5162.69</td><td>3100.07</td></tr><tr><td> pD</td><td>55.18</td><td>55.19</td><td>268.09</td></tr><tr><td> Md (Ď)</td><td>5107.66</td><td>5107.50</td><td>2831.98</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>- significant fixed effects</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec10">
                <title>Temporal characteristics of TB-HIV co-infection epidemics</title>
                <p id="Par44">The temporal trend in TB-HIV co-infection relative risks from 2012 to 2018 is in Fig. <xref rid="Fig5" ref-type="fig">5</xref>. The co-infection risk trend shows an initial steady decrease between 2012 and 2016 then a sharp increase in 2017 that slightly decreases in 2018. The lowest risk of 0.9 was in the year 2016 while the highest risk of 1.07 was in the year 2012.
<fig id="Fig5"><label>Fig. 5</label><caption><p>Temporal trend of co-infection risk in Kenya</p></caption><graphic xlink:href="12879_2019_4540_Fig5_HTML" id="MO5"/></fig></p>
              </sec>
              <sec id="Sec11">
                <title>Spatial patterns of TB-HIV co-infection epidemic</title>
                <p id="Par45">The spatial map in Fig. <xref rid="Fig6" ref-type="fig">6</xref> and the relative risk plot in Fig. <xref rid="Fig7" ref-type="fig">7</xref> present the cumulative predicted values of TB-HIV co-infection risk over a 7-year period (2012–2018) per county. There were 12 counties out of the 47 with high co-infection risk evidenced by values greater than 1. Most of these high-risk counties were towards the further west of Kenya; Homabay County was leading followed by Siaya, Kisumu, Migori and Busia counties.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Spatial pattern of co-infection burden per County (2012–2018)</p></caption><graphic xlink:href="12879_2019_4540_Fig6_HTML" id="MO6"/></fig>
<fig id="Fig7"><label>Fig. 7</label><caption><p>Relative risk plot (2012–2018)</p></caption><graphic xlink:href="12879_2019_4540_Fig7_HTML" id="MO7"/></fig></p>
                <p id="Par46">Figure <xref rid="Fig8" ref-type="fig">8</xref>a shows the spatial pattern of the posterior mean for the country-specific relative risk <inline-formula id="IEq6"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \Big({\upzeta}_{\mathrm{s}}={\mathrm{e}}^{\left({\upxi}_{\mathrm{s}}={\upupsilon}_{\mathrm{s}}+{\upnu}_{\mathrm{s}}\right)} $$\end{document}</tex-math><mml:math id="M26" display="inline"><mml:mspace width="0.25em"/><mml:mo stretchy="true">(</mml:mo><mml:msub><mml:mi mathvariant="normal">ζ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi mathvariant="normal">e</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi mathvariant="normal">ξ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">υ</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">ν</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:msup></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq6.gif"/></alternatives></inline-formula>) of TB-HIV co-infection compared to the whole of Kenya while Fig. <xref rid="Fig8" ref-type="fig">8</xref>b presents the measure of uncertainty associated with the posterior means ζ<sub>s</sub> : P(ζ<sub>s</sub> &gt; 1| y). It is evident that there is an increased co-infection risk in a number of counties characterized by a spatial relative risk above one and a posterior probability of the relative risk above 0.8 indicating a high level of associated certainty.
<fig id="Fig8"><label>Fig. 8</label><caption><p>County-specific relative risks and posterior probabilities</p></caption><graphic xlink:href="12879_2019_4540_Fig8_HTML" id="MO8"/></fig></p>
              </sec>
              <sec id="Sec12">
                <title>Spatiotemporal trends of TB-HIV co-infection epidemics</title>
                <p id="Par47">The probability maps for the space-time interaction relative risk estimates greater than one, <inline-formula id="IEq7"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{P}\left({\mathrm{e}}^{\updelta_{\mathrm{st}}}&gt;1|\mathrm{y}\right) $$\end{document}</tex-math><mml:math id="M28" display="inline"><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">P</mml:mi><mml:mfenced close=")" open="(" separators="|"><mml:mrow><mml:msup><mml:mi mathvariant="normal">e</mml:mi><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi>st</mml:mi></mml:msub></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant="normal">y</mml:mi></mml:mfenced></mml:math><inline-graphic xlink:href="12879_2019_4540_Article_IEq7.gif"/></alternatives></inline-formula>, for the 7 years are in Fig. <xref rid="Fig9" ref-type="fig">9</xref>. These are the exceedance probabilities useful for assessing the unusual elevation of coinfection risk over the 7-year period of study. Only a few counties had a probability of the relative risk being greater than 1 and they varied in different years.
<fig id="Fig9"><label>Fig. 9</label><caption><p>Posterior probabilities for the space-time interaction: 47 counties and 2012–2018 years</p></caption><graphic xlink:href="12879_2019_4540_Fig9_HTML" id="MO9"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec13">
              <title>Discussion</title>
              <p id="Par48">The surveillance data from the National TB program gives deep insights into the TB-HIV co-epidemic. This study established that 96% of the TB case notifications had documented HIV test results, which is greater than the WHO’s global estimate of 64% in 2017 and that of the African region (86%) [<xref ref-type="bibr" rid="CR28">28</xref>]. The significant upturn in the HIV screening practices for every TB case notification in Kenya could be attributed to the commitment from the National TB program and the health professionals in communication and social mobilization for early diagnosis and therapy uptake. Similar observations were reported in Ghana [<xref ref-type="bibr" rid="CR29">29</xref>] and Ethiopia [<xref ref-type="bibr" rid="CR30">30</xref>]. Globally, Kenya registered an 8% TB decline rate per year from 2013 to 2017 amongst other high TB burden countries including the Russian Federation (13%), Ethiopia (12%), Sierra Leone (10%) and Viet Nam at 8% [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
              <p id="Par49">Our findings on the number of TB case notifications per year for the period 2012 to 2018 showed a steady reduction for the period 2012–2016 then a significant rise in 2017 and a slow decrease in 2018. The temporal trend of the coinfection relative risk for the entire country followed a similar pattern as the TB case notifications. From 2012 to 2016, there was a clear downward relative risk trend then a steep upward risk for the year 2017–2018. This could be because of either improvement in TB cases detection or surveillance biases due to spatial heterogeneity in the co-infection dynamics, an observation that is in accord with the conclusions of [<xref ref-type="bibr" rid="CR31">31</xref>]. To maintain the consistent TB decline rates, supplementary efforts to support TB-HIV collaborative activities towards reducing the burden of HIV in TB patients are critical.</p>
              <p id="Par50">The co-infection cases were higher in patients aged between 35 and 54 years with new cases of TB infection. Similarly, the co-infection risk was higher for the same age bracket, which implied that co-infection was more common in the sexually active age group. These findings were contrary to the findings by [<xref ref-type="bibr" rid="CR32">32</xref>] and [<xref ref-type="bibr" rid="CR29">29</xref>] who observed that high rates of TB-HIV co-infections were in younger patients (&lt; 15 years of age) but consistent with several other studies [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. The study also revealed that a larger proportion of the HIV co-infected cases had extra-pulmonary TB conforming to [<xref ref-type="bibr" rid="CR37">37</xref>] and [<xref ref-type="bibr" rid="CR34">34</xref>] who found that the risk of extra-pulmonary TB was higher in HIV co-infected cases majorly because of delayed diagnosis especially for the sputum smear-negative.</p>
              <p id="Par51">In our study, the male TB cases significantly exceeded female cases. However, the risk of co-infection was consistently higher in females than in males for the period 2012–2018. The findings conform to a number of studies showing that females bear a disproportionate burden of TB-HIV co-infection in SSA [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR41">41</xref>]. The larger TB case notification among the male could be because of the barriers the female encounter in seeking care for and diagnosis of TB or could reflect more complete registration for treatment by the male [<xref ref-type="bibr" rid="CR42">42</xref>]. In other studies, by [<xref ref-type="bibr" rid="CR34">34</xref>], the prevalence of co-infection was much higher among males in most countries in Sub-Saharan Africa whereas in all other countries there was no significant difference in the gender ratio. However, the case notification data alone are insufficient to determine whether the gender ratio reflects an excess in the co-infection burden among men or a disadvantage among women in seeking and accessing TB care.</p>
              <p id="Par52">Having proper infrastructure in place is the foundation for planning, delivering and evaluating public health services. The country infrastructure ranking in [<xref ref-type="bibr" rid="CR26">26</xref>] showed counties with infrastructure index below the national average of 0.41 were classified as the most marginalized. In our study, it was evident that counties in the western region of Kenya, that is Homabay, Siaya, Kisumu, Migori, Busia, and Vihiga, have unresolved co-infection dynamics that is echoed by their infrastructure index. Their patterns of co-infection also reinforced the fact that counties with high HIV prevalence also post high TB disease burden [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>] with exception of a few like Wajir, Lamu, Isiolo and West Pokot that have lower HIV incidence rate but high TB burden. We attribute these exceptions to unsuccessful treatment critical to arresting TB re-infection and new infections. In terms of competitive exclusion, TB can exist in places where HIV is of low incidence.</p>
              <p id="Par53">Although TB disproportionately affects persons living with HIV, most of the transmission is by persons without HIV, who typically remain transmissible for a longer period. Since delayed diagnosis influences, the prolongation of infectiousness and effective treatment rapidly attenuates infectiousness [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], initiatives to reduce TB incidence in the general population can help prevent new infections among persons living with HIV.</p>
              <p id="Par54">The primary limitation of the study is using case notification data as a surrogate measure of the general population at risk. Case notifications are data from specific subpopulations who seek treatment and care from health facilities; these are geographically representative of nearby populations. Whereas this kind of data is not completely spatially random for the co-epidemic burden, it still captures the spatiotemporal patterns of incidence risk, which is the ultimate goal of this study.</p>
            </sec>
            <sec id="Sec14">
              <title>Conclusion</title>
              <p id="Par55">We identified elevated risk areas for TB/HIV co-infection and fluctuating temporal trends which could be a result of improved TB case detection or surveillance bias caused by spatial heterogeneity in the co-infection dynamics. The elevated risk areas indicated the need for focused interventions and continuous TB-HIV surveillance. Our study also demonstrated the potential utility of case notification data in providing robust estimates for the broad spatiotemporal structure of the TB-HIV co-epidemic. The findings showed that the high burden counties for TB-HIV co-infection were consistent with findings from previous work done on high burden counties for HIV. This suggested that the TB-HIV co-epidemic in Kenya is still at a critical point portending a dual endemic challenge for many years to come. Much as HIV is a serious challenge in the management of TB, the national response to TB-HIV co-infection promotes HIV testing among TB patients as a strategy to reduce TB transmission. However, the government of Kenya needs to combine surveillance systems for the TB and HIV National programs to optimize the TB-HIV coinfection case notification processes at all levels. With integrated case notification systems at the health facility levels, there will be complete data capture on co-infection incidences and outcomes. Integration of care for both TB and HIV using a single facility and single health provider in each county will enable proper monitoring of the co-infection trends, which will guide policy decisions on access to health care and relevant public health interventions. This will also ensure adequate resource allocation to cause a significant impact on the reduction of HIV burden amongst TB patients and TB burden amongst HIV patients.</p>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>BYM</term>
                  <def>
                    <p id="Par5">Besag-York-Mollie</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CI</term>
                  <def>
                    <p id="Par6">Confidence Interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term>Ď</term>
                  <def>
                    <p id="Par7">Mean deviance</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DIC</term>
                  <def>
                    <p id="Par8">Deviance Information Criterion</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FEM</term>
                  <def>
                    <p id="Par9">Fixed Effects Model</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HIV</term>
                  <def>
                    <p id="Par10">Human Immunodeficiency Virus</p>
                  </def>
                </def-item>
                <def-item>
                  <term>iCAR</term>
                  <def>
                    <p id="Par11">intrinsic Conditional Autoregressive Model</p>
                  </def>
                </def-item>
                <def-item>
                  <term>INLA</term>
                  <def>
                    <p id="Par12">Integrated Nested Laplace Approach</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NLTP</term>
                  <def>
                    <p id="Par13">National Tuberculosis, Leprosy and Lung Disease Program</p>
                  </def>
                </def-item>
                <def-item>
                  <term>pD</term>
                  <def>
                    <p id="Par14">effective number of parameters</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RR</term>
                  <def>
                    <p id="Par15">Relative Risk</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TB</term>
                  <def>
                    <p id="Par16">Tuberculosis</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <p>The authors sincerely thank the National Tuberculosis, Leprosy and Lung Cancer Program (NLTP) for providing the data used in this study. The authors acknowledge the help of Prof Gabriel Magoma for commenting on earlier drafts of the manuscript.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>VO conceived, designed the study and wrote the first draft of the manuscript. VO and TO analyzed data. HM contributed to data analysis. All authors contributed to reviewing literature, interpretation of the results and writing of the manuscript. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>The authors would like to thank the African Union and Pan African University Institute of Basic Sciences Technology and Innovation (PAUISTI) for funding the study through VO’s Ph.D. work. The funders had no role in study design, data collection and analysis, interpretation of results, decision to publish, or preparation of the manuscript.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets used and/ or analyzed during the current study are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Ethics approval and consent to participate</title>
              <p id="Par56">This study used data with all participant identifiers removed. Ethical permission for use of the data in the present study was obtained from National Tuberculosis, Leprosy and Lung Disease Program (NLTP) - Kenya.</p>
            </notes>
            <notes>
              <title>Consent for publication</title>
              <p id="Par57">Not applicable.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par58">The authors declare that they have no competing interests.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumar</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kumar</surname>
                      <given-names>AMV</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Kanchar</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mohammed</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Srinath</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues</article-title>
                  <source>Int J Tuberc Lung Dis</source>
                  <year>2012</year>
                  <volume>16</volume>
                  <issue>5</issue>
                  <fpage>573</fpage>
                  <lpage>578</lpage>
                  <pub-id pub-id-type="doi">10.5588/ijtld.11.0482</pub-id>
                  <?supplied-pmid 22507931?>
                  <pub-id pub-id-type="pmid">22507931</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khan</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Minion</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pai</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Royce</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Burman</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Harries</surname>
                      <given-names>AD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis</article-title>
                  <source>Clin Infect Dis</source>
                  <year>2010</year>
                  <volume>50</volume>
                  <issue>9</issue>
                  <fpage>1288</fpage>
                  <lpage>1299</lpage>
                  <pub-id pub-id-type="doi">10.1086/651686</pub-id>
                  <?supplied-pmid 20353364?>
                  <pub-id pub-id-type="pmid">20353364</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayer</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>CD</given-names>
                    </name>
                  </person-group>
                  <article-title>Synergistic pandemics: confronting the global HIV and Tuberculosis epidemics</article-title>
                  <source>Clin Infect Dis</source>
                  <year>2010</year>
                  <volume>50</volume>
                  <issue>s3</issue>
                  <fpage>S67</fpage>
                  <lpage>S70</lpage>
                  <pub-id pub-id-type="doi">10.1086/651475</pub-id>
                  <?supplied-pmid 20397958?>
                  <pub-id pub-id-type="pmid">20397958</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <mixed-citation publication-type="other">WHO. Global Tuberculosis Report. 2016. Geneva: World Health Organization; 2016. p. 214.</mixed-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nkhoma</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Gikaara</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Sherr</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Harding</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Does being on TB treatment predict a higher burden of problems and concerns among HIV outpatients in Kenya? a cross-sectional self-report study</article-title>
                  <source>AIDS Care</source>
                  <year>2018</year>
                  <volume>30</volume>
                  <issue>sup2</issue>
                  <fpage>28</fpage>
                  <lpage>32</lpage>
                  <pub-id pub-id-type="doi">10.1080/09540121.2018.1469726</pub-id>
                  <?supplied-pmid 29848006?>
                  <pub-id pub-id-type="pmid">29848006</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Whalen</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Zalwango</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Chiunda</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Malone</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Eisenach</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Joloba</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Secondary attack rate of tuberculosis in urban households in Kampala, Uganda</article-title>
                  <source>PLoS One</source>
                  <year>2011</year>
                  <volume>6</volume>
                  <issue>2</issue>
                  <fpage>e16137</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0016137</pub-id>
                  <?supplied-pmid 21339819?>
                  <pub-id pub-id-type="pmid">21339819</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dheda</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Shean</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Zumla</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Badri</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Streicher</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Page-Shipp</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study</article-title>
                  <source>Lancet</source>
                  <year>2010</year>
                  <volume>375</volume>
                  <issue>9728</issue>
                  <fpage>1798</fpage>
                  <lpage>1807</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60492-8</pub-id>
                  <?supplied-pmid 20488525?>
                  <pub-id pub-id-type="pmid">20488525</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patel</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Swan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Tachado</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Koziel</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Impaired M. tuberculosis-mediated apoptosis in alveolar macrophages from HIV+ persons: potential role of IL-10 and BCL-3</article-title>
                  <source>J Leukoc Biol</source>
                  <year>2009</year>
                  <volume>86</volume>
                  <issue>1</issue>
                  <fpage>53</fpage>
                  <lpage>60</lpage>
                  <pub-id pub-id-type="doi">10.1189/jlb.0908574</pub-id>
                  <?supplied-pmid 19383626?>
                  <pub-id pub-id-type="pmid">19383626</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bell</surname>
                      <given-names>LCK</given-names>
                    </name>
                    <name>
                      <surname>Noursadeghi</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection</article-title>
                  <source>Nat Rev Microbiol</source>
                  <year>2017</year>
                  <volume>16</volume>
                  <issue>2</issue>
                  <fpage>80</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrmicro.2017.128</pub-id>
                  <?supplied-pmid 29109555?>
                  <pub-id pub-id-type="pmid">29109555</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van-Rie</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Westreich</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sanne</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies</article-title>
                  <source>J Acquir Immune Defic Syndr</source>
                  <year>2011</year>
                  <volume>56</volume>
                  <issue>4</issue>
                  <fpage>349</fpage>
                  <lpage>355</lpage>
                  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181f9fb39</pub-id>
                  <?supplied-pmid 20926954?>
                  <pub-id pub-id-type="pmid">20926954</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gupta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wood</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kaplan</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bekker</surname>
                      <given-names>L-G</given-names>
                    </name>
                    <name>
                      <surname>Lawn</surname>
                      <given-names>SD</given-names>
                    </name>
                  </person-group>
                  <article-title>Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <issue>3</issue>
                  <fpage>e34156</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0034156</pub-id>
                  <?supplied-pmid 22479548?>
                  <pub-id pub-id-type="pmid">22479548</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Winter</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Adamu</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>RK</given-names>
                    </name>
                    <name>
                      <surname>Stagg</surname>
                      <given-names>HR</given-names>
                    </name>
                    <name>
                      <surname>Delpech</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Abubakar</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence</article-title>
                  <source>Int J Tuberc Lung Dis</source>
                  <year>2018</year>
                  <volume>22</volume>
                  <issue>7</issue>
                  <fpage>713</fpage>
                  <lpage>722</lpage>
                  <pub-id pub-id-type="doi">10.5588/ijtld.17.0672</pub-id>
                  <?supplied-pmid 29914596?>
                  <pub-id pub-id-type="pmid">29914596</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yuen</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Weyenga</surname>
                      <given-names>HO</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Malika</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Muttai</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Katana</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012</article-title>
                  <source>PLoS One</source>
                  <year>2014</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>e99880</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0099880</pub-id>
                  <?supplied-pmid 24937804?>
                  <pub-id pub-id-type="pmid">24937804</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mbithi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gichangi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Katana</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Weyenga</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Tuberculosis and HIV at the national level in Kenya: results from the second Kenya AIDS Indicator survey</article-title>
                  <source>J Acquir Immune Defic Syndr</source>
                  <year>2014</year>
                  <volume>66</volume>
                  <issue>Suppl. 1</issue>
                  <fpage>S106</fpage>
                  <lpage>S115</lpage>
                  <pub-id pub-id-type="doi">10.1097/QAI.0000000000000120</pub-id>
                  <?supplied-pmid 24732814?>
                  <pub-id pub-id-type="pmid">24732814</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <mixed-citation publication-type="other">WHO. Global tuberculosis report. 2015. 20th ed. Geneva: World Health Organization; 2015. p. 192. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/iris/handle/10665/191102">http://www.who.int/iris/handle/10665/191102</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trinh</surname>
                      <given-names>QM</given-names>
                    </name>
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>HL</given-names>
                    </name>
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>VN</given-names>
                    </name>
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>TVA</given-names>
                    </name>
                    <name>
                      <surname>Sintchenko</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Marais</surname>
                      <given-names>BJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Tuberculosis and HIV co-infection-focus on the Asia-Pacific region</article-title>
                  <source>Int J Infect Dis</source>
                  <year>2015</year>
                  <volume>32</volume>
                  <fpage>170</fpage>
                  <lpage>178</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijid.2014.11.023</pub-id>
                  <?supplied-pmid 25809776?>
                  <pub-id pub-id-type="pmid">25809776</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lin</surname>
                      <given-names>W-C</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>H-H</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SS-J</given-names>
                    </name>
                    <name>
                      <surname>Sy</surname>
                      <given-names>C-L</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>K-S</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>J-K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-b</article-title>
                  <source>J Microbiol Immunol Infect</source>
                  <year>2016</year>
                  <volume>49</volume>
                  <issue>5</issue>
                  <fpage>729</fpage>
                  <lpage>736</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jmii.2014.08.010</pub-id>
                  <?supplied-pmid 25442858?>
                  <pub-id pub-id-type="pmid">25442858</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karo</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Krause</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hollo</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>van der Werf</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Castell</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hamouda</surname>
                      <given-names>O</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of HIV infection on treatment outcome of tuberculosis in Europe</article-title>
                  <source>AIDS</source>
                  <year>2016</year>
                  <volume>30</volume>
                  <issue>7</issue>
                  <fpage>1089</fpage>
                  <lpage>1098</lpage>
                  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001016</pub-id>
                  <?supplied-pmid 26752278?>
                  <pub-id pub-id-type="pmid">26752278</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Onyango</surname>
                      <given-names>DO</given-names>
                    </name>
                    <name>
                      <surname>Yuen</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Cain</surname>
                      <given-names>KP</given-names>
                    </name>
                    <name>
                      <surname>Ngari</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Masini</surname>
                      <given-names>EO</given-names>
                    </name>
                    <name>
                      <surname>Borgdorff</surname>
                      <given-names>MW</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya</article-title>
                  <source>PLoS One</source>
                  <year>2017</year>
                  <volume>12</volume>
                  <issue>11</issue>
                  <fpage>e0188235</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0188235</pub-id>
                  <?supplied-pmid 29145454?>
                  <pub-id pub-id-type="pmid">29145454</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Onyango</surname>
                      <given-names>DO</given-names>
                    </name>
                    <name>
                      <surname>Yuen</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Masini</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Borgdorff</surname>
                      <given-names>MW</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiology of pediatric Tuberculosis in Kenya and risk factors for mortality during treatment: A National Retrospective Cohort Study</article-title>
                  <source>J Pediatr</source>
                  <year>2018</year>
                  <volume>201</volume>
                  <fpage>115</fpage>
                  <lpage>121</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpeds.2018.05.017</pub-id>
                  <?supplied-pmid 29885751?>
                  <pub-id pub-id-type="pmid">29885751</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schrödle</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Held</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>A primer on disease mapping and ecological regression using INLA</article-title>
                  <source>Comput Stat</source>
                  <year>2010</year>
                  <volume>26</volume>
                  <issue>2</issue>
                  <fpage>241</fpage>
                  <lpage>258</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00180-010-0208-2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ugarte</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Adin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Goicoa</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Militino</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>On fitting spatio-temporal disease mapping models using approximate Bayesian inference</article-title>
                  <source>Stat Methods Med Res</source>
                  <year>2014</year>
                  <volume>23</volume>
                  <issue>6</issue>
                  <fpage>507</fpage>
                  <lpage>530</lpage>
                  <pub-id pub-id-type="doi">10.1177/0962280214527528</pub-id>
                  <?supplied-pmid 24713158?>
                  <pub-id pub-id-type="pmid">24713158</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blangiardo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Cameletti</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Baio</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Rue</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Spatial and spatio-temporal models with R-INLA</article-title>
                  <source>Spat Spatiotemporal Epidemiol</source>
                  <year>2013</year>
                  <volume>4</volume>
                  <fpage>33</fpage>
                  <lpage>49</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.sste.2012.12.001</pub-id>
                  <?supplied-pmid 23481252?>
                  <pub-id pub-id-type="pmid">23481252</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernardinelli</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Clayton</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pascutto</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Montomoli</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ghislandi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Songini</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Bayesian analysis of space-time variation in disease risk</article-title>
                  <source>Stat Med</source>
                  <year>1995</year>
                  <volume>14</volume>
                  <fpage>2433</fpage>
                  <lpage>2443</lpage>
                  <pub-id pub-id-type="doi">10.1002/sim.4780142112</pub-id>
                  <?supplied-pmid 8711279?>
                  <pub-id pub-id-type="pmid">8711279</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>HDR</collab>
                  </person-group>
                  <source>Technical Note 3</source>
                  <year>2015</year>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>CRA</collab>
                  </person-group>
                  <source>Creating a County Development Index to identify marginalized counties. Nairobi, Kenya</source>
                  <year>2012</year>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richardson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Abellan</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Best</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Bayesian spatio-temporal analysis of joint patterns of male and female lung cancer risks in Yorkshire (UK)</article-title>
                  <source>Stat Methods Med Res</source>
                  <year>2006</year>
                  <volume>15</volume>
                  <issue>4</issue>
                  <fpage>385</fpage>
                  <lpage>407</lpage>
                  <pub-id pub-id-type="doi">10.1191/0962280206sm458oa</pub-id>
                  <?supplied-pmid 16886738?>
                  <pub-id pub-id-type="pmid">16886738</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>WHO</collab>
                  </person-group>
                  <source>TB burden estimates, notifications and treatment outcomes: For individual countries and territories, WHO regions and the world</source>
                  <year>2018</year>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Osei</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Der</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Owusu</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kofie</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Axame</surname>
                      <given-names>WK</given-names>
                    </name>
                  </person-group>
                  <article-title>The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control</article-title>
                  <source>BMC Infect Dis</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>504</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12879-017-2598-z</pub-id>
                  <?supplied-pmid 28724359?>
                  <pub-id pub-id-type="pmid">28724359</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tarekegne</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Jemal</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Atanaw</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Ebabu</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Endris</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Moges</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema hospital, Northwest Ethiopia: a 3 years retrospective study</article-title>
                  <source>BMC Res Notes</source>
                  <year>2016</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>192</fpage>
                  <lpage>198</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13104-016-2004-8</pub-id>
                  <?supplied-pmid 27026410?>
                  <pub-id pub-id-type="pmid">27026410</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanchez</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bartholomay</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Arakaki-Sanchez</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Enarson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Bissell</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Barreira</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <issue>3</issue>
                  <fpage>e33129</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0033129</pub-id>
                  <?supplied-pmid 22457738?>
                  <pub-id pub-id-type="pmid">22457738</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davy-Mendez</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shiau</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Okada</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Moss</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Murgai</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Combining surveillance systems to investigate local trends in tuberculosis-HIV co-infection</article-title>
                  <source>AIDS Care</source>
                  <year>2019</year>
                  <volume>7</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1080/09540121.2019.1659920</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sánchez</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Lloyd-Smith</surname>
                      <given-names>JO</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>BG</given-names>
                    </name>
                    <name>
                      <surname>Porco</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>Ryan</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Borgdorff</surname>
                      <given-names>MW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other</article-title>
                  <source>Epidemics</source>
                  <year>2009</year>
                  <volume>1</volume>
                  <issue>1</issue>
                  <fpage>14</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.epidem.2008.08.001</pub-id>
                  <?supplied-pmid 21352748?>
                  <pub-id pub-id-type="pmid">21352748</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Manjareeka</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Nanda</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of HIV infection among tuberculosis patients in Eastern India</article-title>
                  <source>J Infect Public Health</source>
                  <year>2013</year>
                  <volume>6</volume>
                  <issue>5</issue>
                  <fpage>358</fpage>
                  <lpage>362</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jiph.2013.04.004</pub-id>
                  <?supplied-pmid 23999356?>
                  <pub-id pub-id-type="pmid">23999356</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van der Werf</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Ködmön</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zucs</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hollo</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Amato-Gauci</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Pharris</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles</article-title>
                  <source>AIDS</source>
                  <year>2016</year>
                  <volume>30</volume>
                  <issue>18</issue>
                  <fpage>2845</fpage>
                  <lpage>2853</lpage>
                  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001252</pub-id>
                  <?supplied-pmid 27755106?>
                  <pub-id pub-id-type="pmid">27755106</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chanda-Kapata</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kapata</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Klinkenberg</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Grobusch</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Cobelens</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>The prevalence of HIV among adults with pulmonary TB at a population level in Zambia</article-title>
                  <source>BMC Infect Dis</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>236</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12879-017-2345-5</pub-id>
                  <?supplied-pmid 28356081?>
                  <pub-id pub-id-type="pmid">28356081</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>JY</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis and treatment of extrapulmonary tuberculosis</article-title>
                  <source>Tuberc Respir Dis (Seoul)</source>
                  <year>2015</year>
                  <volume>78</volume>
                  <issue>2</issue>
                  <fpage>47</fpage>
                  <lpage>55</lpage>
                  <pub-id pub-id-type="doi">10.4046/trd.2015.78.2.47</pub-id>
                  <pub-id pub-id-type="pmid">25861336</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Magadi</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys</article-title>
                  <source>Sociol Health Illn</source>
                  <year>2011</year>
                  <volume>33</volume>
                  <issue>4</issue>
                  <fpage>522</fpage>
                  <lpage>539</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1467-9566.2010.01304.x</pub-id>
                  <?supplied-pmid 21545443?>
                  <pub-id pub-id-type="pmid">21545443</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sitienei</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Nyambati</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Borus</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>The epidemiology of smear positive Tuberculosis in three TB/HIV high Burden provinces of Kenya (2003–2009)</article-title>
                  <source>Epidemiol Res Int [Internet]</source>
                  <year>2013</year>
                  <volume>2013</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1155/2013/417038</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sia</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Onadja</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Nandi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Foro</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Brewer</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>What lies behind gender inequalities in HIV/AIDS in sub-Saharan African countries: evidence from Kenya, Lesotho and Tanzania</article-title>
                  <source>Health Policy Plan</source>
                  <year>2014</year>
                  <volume>29</volume>
                  <issue>7</issue>
                  <fpage>938</fpage>
                  <lpage>949</lpage>
                  <pub-id pub-id-type="doi">10.1093/heapol/czt075</pub-id>
                  <?supplied-pmid 24345343?>
                  <pub-id pub-id-type="pmid">24345343</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sia</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Onadja</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hajizadeh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Heymann</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Brewer</surname>
                      <given-names>TF</given-names>
                    </name>
                    <name>
                      <surname>Nandi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <source>BMC Public Health</source>
                  <year>2016</year>
                  <volume>16</volume>
                  <issue>1</issue>
                  <fpage>1136</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-016-3783-5</pub-id>
                  <?supplied-pmid 27809824?>
                  <pub-id pub-id-type="pmid">27809824</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horton</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>MacPherson</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Houben</surname>
                      <given-names>RMGJ</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Corbett</surname>
                      <given-names>EL</given-names>
                    </name>
                  </person-group>
                  <article-title>Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis</article-title>
                  <source>PLoS Med</source>
                  <year>2016</year>
                  <volume>3</volume>
                  <issue>9</issue>
                  <fpage>e1002119</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pmed.1002119</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>YC</surname>
                      <given-names>MN</given-names>
                    </name>
                  </person-group>
                  <article-title>On Gaussian Markov Random Fields and Bayesian disease mapping</article-title>
                  <source>Stat Methods Med Res</source>
                  <year>2011</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>49</fpage>
                  <lpage>68</lpage>
                  <pub-id pub-id-type="doi">10.1177/0962280210371561</pub-id>
                  <pub-id pub-id-type="pmid">20547586</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cuadros</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Branscum</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Akullian</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Jia</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Mziray</surname>
                      <given-names>EN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mapping the spatial variability of HIV infection in Sub-Saharan Africa: Effective information for localized HIV prevention and control</article-title>
                  <source>Sci Rep</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <issue>1</issue>
                  <fpage>9093</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-09464-y</pub-id>
                  <?supplied-pmid 28831171?>
                  <pub-id pub-id-type="pmid">28831171</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dye</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Glaziou</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Raviglione</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Prospects for Tuberculosis elimination</article-title>
                  <source>Annu Rev Public Health [Internet]</source>
                  <year>2013</year>
                  <volume>34</volume>
                  <issue>1</issue>
                  <fpage>271</fpage>
                  <lpage>286</lpage>
                  <pub-id pub-id-type="doi">10.1146/annurev-publhealth-031912-114431</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nardell</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Dharmadhikari</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <source>Int J Tuberc Lung Dis</source>
                  <year>2010</year>
                  <volume>14</volume>
                  <issue>10</issue>
                  <fpage>1233</fpage>
                  <lpage>1243</lpage>
                  <?supplied-pmid 20843413?>
                  <pub-id pub-id-type="pmid">20843413</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
